Immune Thrombocytopenic Purpura following Administration of mRNA-Based SARS-CoV-2 and MMR Vaccinations: A Cautionary Tale

We report a case of immune thrombocytopenic purpura (ITP) in an otherwise healthy 31-year-old man following coadministration of the live measles, mumps, and rubella (MMR) vaccine with the Pfizer-BioNTech mRNA SARS-CoV-2 vaccine. The patient was hospitalized briefly and treated for ITP with glucocort...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Whitney, Albano, Adam, Kirkel, Dean, Rouhizad, Nason, Arinze, Folasade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502103/
https://www.ncbi.nlm.nih.gov/pubmed/34635874
http://dx.doi.org/10.1155/2021/2704249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502103/
https://www.ncbi.nlm.nih.gov/pubmed/34635874
http://dx.doi.org/10.1155/2021/2704249

Ejemplares similares